ABOUT 5th_NIF
> ATTENDEES
> INVESTORS​
> SHOWCASES​
> SPONSORS​
> SUPPORTERS​
PARTICIPATING COMPANIES INCLUDE:
3B Future Health Fund
3E Bioventures
5AM Venture Management LLC
6 Dimensions Capital
AbbVie Ventures
AbbVie, Inc.
Abingworth LLP
AcureX Therapeutics Corporation
AffaMed Therapeutics
AI Therapeutics, Inc.
Aisling Capital LLC
Alectos Therapeutics, Inc.
Alfidi Capital
Algonist Biotechnologies GmbH
AlgoTherapeutix SAS
Allele Capital Partners
Allyx Therapeutics, Inc.
Alpha Blue Ocean Ltd
Alpha Bronze LLC
Alta Life Sciences
Alterity Therapeutics
Alto Neuroscience
Altoida, Inc.
Alzheimer's Drug Discovery Foundation
AMO Pharma Ltd.
Anacalypsis Therapeutics
Andera Partners
ANeuroTech
Angelini Pharma S.p.A.
Anima Biotech, Inc.
APstem Therapeutics, Inc.
Aqua Partners LLC
ARCH Venture Partners
Argobio Studio
Arix Bioscience plc
ARTO AG
ASDERA LLC
Asklepios Advisors
Atai Life Sciences
ATGN Consulting
Autobahn Therapeutics, Inc.
BIAL Biotech
Bio Med Gene Ventures
Bioasis Technologies, Inc.
BioCentury, Inc.
Biohaven Pharmaceuticals
BioPharma Drug Licensing Group SL
Bioqube Ventures
BioScience Managers Pty Ltd
BIOSTART Consulting GmbH
BioVie Inc.
Bradley Woods & Co. Ltd.
Brainstorm Cell Therapeutics, Inc.
Braintale
Brandon Capital Partners
Breslin AG
Breslin AG & LSFA
Brookline Capital Markets
BROTHERS & Partners Europe
BTIG, LLC
Canaccord Genuity LLC
Cary Pharmaceuticals Inc.
Catalytic Impact Foundation, Inc.
Cedar Street Capital LLC
Cederberg GmbH
Cenna Biosciences, Inc.
Centrexion Therapeutics Corp.
Cerecin Inc.
CereVasc
CereVasc, LLC
CereVu Medical, Inc.
Clexio Biosciences Ltd.
Cognition Therapeutics, Inc.
Cognito Therapeutics, Inc.
Collaborations Pharmaceutical., Inc.
Connecticut Innovations
Convergence Partners AG
Cresco Advisors LLC
CTI Life Sciences
Daiichi Sankyo
Dance4Healing
DEFTA Partners
Dementia Discovery Fund - SV Health Investors LLP
Deutsche Bank AG
Droege Group
Eight Roads Venture
EIT Health Investor Network
Eli Lilly and Company
EpiVario, Inc.
Ferghana Partners LLP
Finnadvance
Forbion
Fortunatus Capital
Forty51 Ventures
Foundation Fighting Blindness
Fraser Finance
FreeMind Group
Fuji Chemical Industries Co., Ltd.
Gate Neurosciences, Inc.
GCF Family Office
Generation Fund Life Sciences Fund I
Gimv NV
GL Capital Group
Global Founders Capital
Global Investment Bridge AG
Global Life Science Ventures GmbH
H. Lundbeck A/S
HBM Partners AG
Health Innovation Capital
HealthCap
Herantis Pharma Plc
Hestia Investments Ltd.
IAG / Bio Capital
Iaso Ventures
ICF Consult Switzerland
Illumina Accelerator
Illumina Ventures
Indaco Venture Partners SGR SpA
INKEF Capital BV
Inveready
Invivo Capital Partners, S.G.E.I.C, S.A
IPF Partners
Ipsen
Johnson & Johnson Innovation LLC
Johnston Associates, Inc.
Keystone Bio, Inc.
Kicker Ventures
Kinoxis Therapeutics Pty Ltd
Kreos Capital
Kurma Partners
Lachesis Biosciences Ltd
Ladenburg Thalmann & Co. Inc.
Landmark Family Office, Inc.
LBBW Venture Capital GmbH
LifeLink Ventures
LMU Munich
Longliv Ventures
LSP (Life Sciences Partners)
Lucia Capital
Lumira Ventures
Lundbeckfonden Ventures / Lundbeckfonden Emerge
M Ventures
Magnolia Neurosciences Corporation
Magnus Medical
MarvelBiome, Inc
Medicxi
MEDiSTRAVA Consulting
MedPro Investors LLC
Merck KGaA, Darmstadt, Germany
MetaCell
Mid Atlantic Bio Angels
Minoryx Therapeutics
Mission BioCapital
Mitsui & Co. Global Investment, Inc.
Mizuho Securities USA LLC
MP Healthcare Venture Management, Inc.
MSD
Murdock Capital Partners
National Institute on Aging
NervGen Pharma Corp.
NeuroDiagnostics, Inc. dba Synaps Dx
NeuroEM Therapeutics, Inc.
Neuromity Therapeutics, Inc.
NeuroPn Therapeutics
Neurvati Neurosciences, Inc.
New Harbor Venture Partners, LLC
New York Academy of Sciences
NI Research Inc.
NLS Pharmaceutics AG
NMD Pharma A/S
Northpond Ventures, LLC
NovaQuest Capital Management
Novartis International AG
Novo Ventures
NRW.BANK
Omega Fund Management, LLC
Omnes Capital
Ontario Brain Institute
Oppenheimer & Co. Inc.
Optimum Strategic Communications
Origenis GmbH
Otsuka Pharmaceutical Co., Ltd.
Oxular Limited
Panacea Venture
Panakès Partners SGR SpA
Parkinson's UK
Pathena
PathMaker Neurosystems Inc.
Pfizer Ventures
PharmaVentures Ltd.
PIXIUM VISION SA
PJT Partners
Playground Global
PMV NV
Portugal Ventures SCR, SA
PrecisionLife
Prevail Partners LLC
Pritzker Neuropsychiatric Disorders Research Consortium
Privilège Ventures
Prothena Corporation plc
Qiming Venture Partners US
Quan Capital
Queen Mary University London
QurAlis LLC
Redalpine Venture Partners AG
Rejuveron Life Sciences AG
Remiges Ventures
Reviva Pharmaceuticals, Inc.
Roivant Sciences GmbH
RSJ Investments
RYSE Asset Management
Sand Hill Angels
SciNeuro Pharmaceuticals
Sense Neuro Diagnostics
Seroba Life Sciences
Servier BioInnovation
Shadow Lake Group Inc
Simcere Pharmaceutical Group
Sofinnova Investments
Sound Bioventures Management AB
Spirify Pharma, Inc.
STALICLA SA
Starlight Investments LLC
Stealth BioTherapeutics Inc.
SternAegis Ventures
Sunovion Pharmaceuticals, Inc.
Sunstone Life Science Ventures A/S
SVB Leerink
Synaptogenix, Inc.
Taiho Ventures, LLC
Takeda Digital Ventures LP
Takeda Pharmaceuticals Co., Ltd.
TechWald Holding S.p.A.
Tessara Therapeutics Pty Ltd.
The Benchmark Company, LLC
The Michael J. Fox Foundation for Parkinson's Research
The Plummer Hill Group, LLC
TikoMed AB
Tonix Pharmaceuticals Holding Corp.
Toscana Ventures, LLC
TransPacific Venture Capital Partners
Trillium Medical Ventures
TruVenturo GmbH
UCB Pharma
Ultreum Life Science DMCC
Umecrine Cognition AB
Unlearn.AI, Inc.
V-Bio Ventures BV
Vallon Pharmaceuticals, Inc.
VCapital Management Co., LLC
VI Partners AG
Vickers Venture Partners
Vida Ventures, LLC
VIV Capital
VU Venture Partners
WA4STEAM
WaveEdge Capital LLC
WBB Securities
Weill Cornell Medical College
WG Partners LLP
Wille Finance AG
WPSS Investments
WRF Capital
XOventure GmbH
Ysios Capital
Zambon S.p.A.
Zeto, Inc.
More TBA...
Last updated on: 22nd of March 2022